1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide has been researched along with Canine Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boari, A; Bongiovanni, L; Cabibbo, E; Crisi, PE; Finotello, R; Ressel, L; Rinaldi, V | 1 |
| Aralla, M; Chalfon, C; Cola, V; Dobson, J; Ferraris, E; Finotello, R; Gramer, I; Marconato, L; Morello, EM; Morris, JS; Polton, G; Ramos, S; Sabattini, S; Schiavo, L | 1 |
2 other study(ies) available for 1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide and Canine Diseases
| Article | Year |
|---|---|
Expression of cannabinoid receptors CB1 and CB2 in canine cutaneous mast cell tumours.
Topics: Animals; CME-Carbodiimide; Dog Diseases; Dogs; Mast Cells; Neoplasms; Receptor, Cannabinoid, CB1 | 2022 |
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi-institutional retrospective study.
Topics: Animals; Dog Diseases; Dogs; Lymphatic Metastasis; Mastocytoma, Skin; Prognosis; Retrospective Studies | 2023 |